Exosome long non-coding RNA SOX2-OT contributes to ovarian cancer malignant progression by miR-181b-5p/SCD1 signaling
Authors:
Open Access
- 24 October 2021
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 13 (20) , 23726-23738
Abstract
Ovarian cancer is a common gynecologic cancer with increased mortality and morbidity. Exosome-delivered long non-coding RNAs have been well found in cancer development. However, the function of exosomal SOX2-OT in ovarian cancer development is still unreported. In the present study, we were interested in the investigation of the effect of exosomal SOX2-OT during ovarian cancer pathogenesis. Significantly, we revealed that the SOX2-OT expression levels were up-regulated in the ovarian cancer patients’ plasma exosomes. The depletion of exosomal SOX2-OT inhibited migration, invasion, and proliferation and induced apoptosis in ovarian cancer cells. In mechanical exploration, SOX2-OT could sponge miR-181b-5p, and miR-181b-5p was able to target SCD1 in the ovarian cancer cells. The SCD1 overexpression and miR-181b-5p inhibitor could reverse exosomal SOX2-OT-mediated ovarian cancer progression. Functionally, the depletion of exosomal SOX2-OT significantly reduced tumor growth of ovarian cancer cells in vivo. In summary, we concluded that exosomal SOX2-OT enhanced ovarian cancer malignant phenotypes by miR-181b-5p/SCD1 axis. Our finding presents novel insights into the mechanism by which exosomal lncRNA SOX2-OT promotes ovarian cancer progression. SOX2-OT, miR-181b-5p, and SCD1 may serve as potential targets for the treatment of ovarian cancer.Keywords
This publication has 38 references indexed in Scilit:
- Commentary: Mendelian randomization analysis identifies circulating vitamin D as a causal risk factor for ovarian cancerInternational Journal of Epidemiology, 2016
- Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1Nature Communications, 2016
- Exosome mediated communication within the tumor microenvironmentJournal of Controlled Release, 2015
- Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinomaJournal of Surgical Research, 2014
- Decreasing stearoyl‐CoA desaturase‐1 expression inhibits β‐catenin signaling in breast cancer cellsCancer Science, 2012
- Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human resultsNature Medicine, 2011
- Inhibition of StearoylCoA Desaturase Activity Blocks Cell Cycle Progression and Induces Programmed Cell Death in Lung Cancer CellsPLOS ONE, 2010
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cellsOncogene, 2010
- Central adiposity as a major risk factor of ovarian cancer.2009
- Family history of breast cancer as a risk factor for ovarian cancer in a prospective studyCancer, 2006